Federation des caisses Desjardins du Quebec’s Ionis Pharmaceuticals IONS Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$953K	Buy	12,017 +2,012	+20%	+$151K	﹤0.01%	1124
2026 Q1	$751K	Sell	10,005 -2,548	-20%	-$201K	﹤0.01%	1112
2025 Q4	$993K	Buy	+12,553	New	+$945K	﹤0.01%	997
2021 Q4	–	Sell	-200	Closed	-$6.71K	–	2558
2021 Q3	$6.71K	Buy	+200	New	+$7.54K	﹤0.01%	2164
2021 Q2	–	Sell	-1,271	Closed	-$57.2K	–	2545
2021 Q1	$57.2K	Hold	1,271	–	–	﹤0.01%	1504
2020 Q4	$71.9K	Buy	+1,271	New	+$63.3K	﹤0.01%	1376
2020 Q1	–	Sell	-18,730	Closed	-$1.13M	–	2285
2019 Q4	$1.13M	Buy	+18,730	New	+$1.12M	0.02%	625
2018 Q1	–	Sell	-29	Closed	-$1.46K	–	2182
2017 Q4	$1.46K	Hold	29	–	–	﹤0.01%	2019
2017 Q3	$1.47K	Sell	29 -100	-78%	-$5.24K	﹤0.01%	1965
2017 Q2	$6.56K	Buy	+129	New	+$6.01K	﹤0.01%	1834

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's IONS Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Ionis Pharmaceuticals (IONS) stake by 20% in Q2 2026, buying an estimated $151K and bringing the position to 12,017 shares worth $953K. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

Federation des caisses Desjardins du Quebec first reported a position in IONS in Q2 2017 and has held it in 10 quarters since. The position peaked at $1.13M in Q4 2019. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Federation des caisses Desjardins du Quebec held 12,017 shares of Ionis Pharmaceuticals worth $953K as of Q2 2026.
Federation des caisses Desjardins du Quebec bought 2,012 Ionis Pharmaceuticals shares in Q2 2026, an estimated $151K.
Ionis Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1124 holding.
Federation des caisses Desjardins du Quebec first reported a position in Ionis Pharmaceuticals in Q2 2017 and has held it in 10 quarters since.
Federation des caisses Desjardins du Quebec's Ionis Pharmaceuticals position peaked at $1.13M in Q4 2019.
515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.